Transition of young adults with metabolic bone diseases to adult care
As more accurate diagnostic tools and targeted therapies become increasingly available for pediatric metabolic bone diseases, affected children have a better prognosis and significantly longer lifespan. With this potential for fulfilling lives as adults comes the need for dedicated transition and in...
Main Authors: | Jordan Ross, Michelle R. Bowden, Christine Yu, Alicia Diaz-Thomas |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2023.1137976/full |
Similar Items
-
Complications and Treatments in Adult X-Linked Hypophosphatemia
by: Yasuo Imanishi, et al.
Published: (2022-09-01) -
A novel c.2179T>C mutation blocked the intracellular transport of PHEX protein and caused X‐linked hypophosphatemic rickets in a Chinese family
by: Baowei Li, et al.
Published: (2020-08-01) -
The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data
by: Gema Ariceta, et al.
Published: (2023-09-01) -
Hereditary Metabolic Bone Diseases: A Review of Pathogenesis, Diagnosis and Management
by: Nipith Charoenngam, et al.
Published: (2022-10-01) -
Genetic analysis of hypophosphatemic rickets in Malaysian patients through whole exome sequencing
by: Nahid, Tavana
Published: (2021)